Has Phuong Nguyen received payments from drug or device companies?

Yes. Drug and device makers reported $5,616 in general payments to Phuong Nguyen across 184 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Phuong Nguyen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Phuong Nguyen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Phuong Nguyen

Psychiatric/Mental Health · Philadelphia, PANPI 1336505064

Payments from drug & device makers

$5,616in general payments, 2019–2025

Across 184 payments — averaging $30.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$1K
Otsuka America Pharmaceutical, Inc.$631
AbbVie$593
Johnson & Johnson$549
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$525
Vanda Pharmaceuticals Inc.$484
plus $2K from 9 others

What the payments were for

Food & beverage$5,50798%
Education$1092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	30	$1,224
Otsuka America Pharmaceutical, Inc.	29	$631
AbbVie	26	$593
Johnson & Johnson	16	$549
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	27	$525
Vanda Pharmaceuticals Inc.	14	$484
Alkermes, Inc.	17	$472
E.r. Squibb & Sons, L.L.C.	5	$304
Braeburn Inc.	3	$278
Neurocrine Biosciences, Inc.	5	$230
Lundbeck LLC	7	$132
TELA Bio, Inc.	1	$93
Bioxcel Therapeutics, Inc.	1	$48
Takeda Pharmaceuticals U.S.A., Inc.	2	$36
Luye Pharma (USA) Ltd.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,616 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	40	$103,060
RexultiBrexpiprazole	12	$19,360
SuboxoneBuprenorphine Hcl/Naloxone Hcl	60	$10,558
Aripiprazole	87	$6,569
Lurasidone Hcl	40	$5,734
Vilazodone Hcl	16	$1,861
Olanzapine	75	$1,564
Asenapine Maleate	11	$1,557
Haloperidol	33	$1,393
Fluphenazine Decanoate	13	$1,156
Divalproex Sodium ErDivalproex Sodium	39	$1,055
Sertraline Hcl	135	$1,036
Benztropine Mesylate	110	$1,021
Buspirone Hcl	57	$921
Perphenazine	18	$839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna	$549	$103,06040 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$631	$19,36012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Philadelphia

Andrew RenziPhiladelphia$13K
Clement JohnPhiladelphia$13K
Rena LindenPhiladelphia$9K
Gordon ZeisPhiladelphia$8K
Kimberly GarciaAllentown$573K
Cortney SmithWashington$227K
Britney KeplerPittsburgh$158K
Kirstyn KamegBethel Park$136K
Anna DipietroDowningtown$131K
Deena MasciocchiLanghorne$71K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →